Fortive Corp. (FTV) has completed the tax-free spin-off of its Precision Technologies business into Ralliant Corp. (RAL), with when-issued trading commencing June 25, 2025, and regular-way trading set for June 30. This strategic separation allows Fortive to concentrate on its higher-growth, higher-margin Intelligent Operating Solutions and Advanced Healthcare Solutions segments, which boast 50% recurring revenue and project $4 billion in revenue with 29% EBITDA margins post-split. Ralliant, the more capital-intensive entity, assumed $1.15 billion in debt to fund a dividend to Fortive, enabling Fortive to repay debt and execute share buybacks. Analysts view Fortive (ex-Ralliant) as the more attractive investment opportunity, citing its enhanced margin profile and capital return program, with a 12-month price target of $62.70 compared to Ralliant's $52.40.
Fortive Corp. has executed a strategic separation by spinning off its Precision Technologies business into a new publicly traded entity, Ralliant Corp. (RAL). This move refines Fortive's focus onto its higher-growth, higher-margin Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) segments, which collectively generate approximately $4 billion in revenue with a significant 50% recurring revenue base and a 29% adjusted EBITDA margin. The transaction is financially accretive for the remaining Fortive entity, which receives a $1.15 billion dividend from Ralliant. These proceeds are earmarked for deleveraging, with $700 million allocated to debt repayment to help reach a target leverage of 2.5x, and the remainder supporting a $550 million share repurchase program. In contrast, Ralliant emerges as a more capital-intensive entity with a lower growth trajectory, forecasting 3.5% revenue growth in FY25 and an adjusted EBITDA margin of 23.7%. Ralliant commences operations with a leverage of 1.9x. The valuation reflects this strategic divergence: Fortive's core segments are valued at premium multiples (up to 19x 2026E EBITDA for IOS) leading to a $62.70 price target, whereas Ralliant is assigned a discounted 12.4x multiple, resulting in a $52.40 price target.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment